Aeglea BioTherapeutics, Inc.
NASDAQ:AGLE
12.01 (USD) • At close November 27, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0.688 | 0.198 | 0.168 | 0.174 | 0.625 | 1.362 | 3.644 | 1.399 | 13.696 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.378 | 1.51 | 1.482 | 1.261 | 1.479 | 0.982 | 1.247 | 1.149 | 1.373 | 0.859 | 1.585 | 1.073 | 3.427 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0.688 | 0.198 | 0.168 | 0.174 | 0.625 | 1.362 | 3.644 | 1.399 | 13.696 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.378 | 1.51 | 1.482 | 1.261 | 1.479 | 0.982 | 1.247 | 1.149 | 1.373 | 0.859 | 1.585 | 1.073 | 3.427 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 24.66 | 17.386 | 13.776 | 14.251 | 11.977 | 15.373 | 16.978 | 16.782 | 14.853 | 13.579 | 11.855 | 15.756 | 12.451 | 16.869 | 14.562 | 17.566 | 17.839 | 14.806 | 14.389 | 11.798 | 8.929 | 9.122 | 6.87 | 5.791 | 6.239 | 5.835 | 4.949 | 4.741 | 5.385 | 4.42 | 3.596 | 3.966 | 3.129 | 2.736 | 1.622 | 2.553 | 2.487 | 1.257 | 0.533 |
| General & Administrative Expenses
| 8.584 | 12.062 | 5.228 | 5.079 | 6.952 | 7.675 | 8.825 | 7.304 | 6.839 | 6.822 | 6.354 | 7.02 | 5.672 | 4.691 | 4.46 | 4.343 | 4.307 | 3.816 | 3.268 | 3.507 | 3.314 | 2.926 | 2.885 | 2.317 | 3.02 | 2.364 | 2.364 | 2.049 | 2.065 | 2.448 | 1.83 | 1.616 | 1.361 | 2.123 | 0.847 | 0.628 | 0.653 | 0.469 | 0.324 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.584 | 12.062 | 5.228 | 5.079 | 6.952 | 7.675 | 8.825 | 7.304 | 6.839 | 6.822 | 6.354 | 7.02 | 5.672 | 4.691 | 4.46 | 4.343 | 4.307 | 3.816 | 3.268 | 3.507 | 3.314 | 2.926 | 2.885 | 2.317 | 3.02 | 2.364 | 2.364 | 2.049 | 2.065 | 2.448 | 1.83 | 1.616 | 1.361 | 2.123 | 0.847 | 0.628 | 0.653 | 0.469 | 0.324 |
| Other Expenses
| 2.342 | -0.008 | -0.072 | -0.032 | 0.024 | 0.005 | -0.03 | -0.015 | -0.024 | -0.052 | -0.031 | 0.018 | 0.002 | -0.019 | -0.006 | -0.018 | -0.012 | -0.016 | -0.017 | -0.02 | -0.013 | -0.007 | -0.017 | -0.007 | -0.012 | -0.012 | -0.011 | -0.012 | -0.009 | -0.009 | -0.006 | -0.001 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 33.244 | 29.448 | 19.004 | 19.33 | 18.929 | 23.048 | 25.803 | 24.086 | 21.692 | 20.401 | 18.209 | 22.776 | 18.123 | 21.56 | 19.022 | 21.909 | 22.146 | 18.622 | 17.657 | 15.305 | 12.243 | 12.048 | 9.755 | 8.108 | 9.259 | 8.199 | 7.313 | 6.79 | 7.45 | 6.868 | 5.426 | 5.582 | 4.49 | 4.859 | 2.469 | 3.181 | 3.14 | 1.726 | 0.857 |
| Operating Income
| -18.337 | -159.246 | -18.806 | -19.162 | -18.755 | -22.423 | -24.441 | -20.442 | -20.293 | -6.705 | -18.209 | -22.776 | -18.123 | -21.56 | -19.022 | -21.909 | -22.146 | -18.622 | -17.657 | -15.305 | -12.243 | -9.67 | -8.245 | -6.626 | -7.998 | -6.72 | -6.331 | -5.543 | -6.301 | -5.495 | -4.567 | -3.997 | -3.417 | -1.432 | -2.469 | -3.181 | -3.14 | -1.726 | -0.857 |
| Operating Income Ratio
| 0 | -231.462 | -94.98 | -114.06 | -107.787 | -35.877 | -17.945 | -5.61 | -14.505 | -0.49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.066 | -5.46 | -4.471 | -6.343 | -4.544 | -6.447 | -4.445 | -5.484 | -4.002 | -5.317 | -2.522 | -3.185 | -0.418 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -21.767 | -188.664 | 0.348 | 0.378 | 0.312 | 0.005 | -0.03 | -0.015 | -0.024 | -0.052 | -0.031 | 0.018 | 0.002 | -0.019 | -0.006 | -0.018 | -0.012 | -0.016 | -0.017 | -0.02 | -0.013 | -0.007 | -0.017 | -0.007 | -0.012 | -0.012 | -0.011 | -0.012 | -0.009 | -0.009 | -0.006 | -0.001 | -0.001 | 0.005 | 0.001 | 0 | -0.111 | -0.67 | -0.663 |
| Income Before Tax
| -40.104 | -217.074 | -18.458 | -18.784 | -18.443 | -22.314 | -24.436 | -20.423 | -20.281 | -6.738 | -18.218 | -22.714 | -18.033 | -21.418 | -18.728 | -21.495 | -21.573 | -18.019 | -17.167 | -14.898 | -11.917 | -9.414 | -8.119 | -6.483 | -7.874 | -6.632 | -6.247 | -5.483 | -6.238 | -5.43 | -4.547 | -3.987 | -3.413 | -1.427 | -2.468 | -3.181 | -3.25 | -2.396 | -1.52 |
| Income Before Tax Ratio
| 0 | -315.515 | -93.222 | -111.81 | -105.994 | -35.702 | -17.941 | -5.605 | -14.497 | -0.492 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.959 | -5.377 | -4.374 | -6.244 | -4.484 | -6.362 | -4.397 | -5.429 | -3.955 | -5.293 | -2.515 | -3.181 | -0.416 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.003 | 0.007 | -0.036 | 0.038 | -0.209 | 0.009 | -0.035 | 0.023 | 0.026 | 0.092 | -0.022 | -0.044 | -0.088 | -0.161 | -0.3 | -0.538 | -0.585 | -0.619 | -0.507 | -0.427 | -0.339 | -0.263 | -0.143 | -0.15 | -0.136 | -0.1 | -0.095 | -0.072 | -0.072 | -0.074 | -0.055 | -0.011 | -0.005 | 0 | 0 | 0 | 0.11 | 0.67 | 0.663 |
| Net Income
| -40.107 | -217.081 | -18.422 | -18.822 | -18.234 | -22.323 | -24.436 | -20.446 | -20.307 | -6.83 | -18.218 | -22.714 | -18.033 | -21.418 | -18.728 | -21.495 | -21.573 | -18.019 | -17.167 | -14.898 | -11.917 | -9.414 | -8.119 | -6.483 | -7.874 | -6.632 | -6.247 | -5.483 | -6.238 | -5.43 | -4.547 | -3.987 | -3.413 | -1.427 | -2.468 | -3.181 | -3.25 | -2.396 | -1.52 |
| Net Income Ratio
| 0 | -315.525 | -93.04 | -112.036 | -104.793 | -35.717 | -17.941 | -5.611 | -14.515 | -0.499 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.959 | -5.377 | -4.374 | -6.244 | -4.484 | -6.362 | -4.397 | -5.429 | -3.955 | -5.293 | -2.515 | -3.181 | -0.416 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -9.34 | -56.79 | -4.89 | -4.93 | -4.84 | -6.79 | -9.26 | -7.75 | -7.72 | -2.6 | -6.94 | -8.73 | -7.24 | -10.11 | -14.15 | -16.28 | -16.4 | -13.72 | -14.79 | -15.54 | -13.55 | -11.43 | -12.17 | -9.77 | -12 | -11.75 | -11.68 | -10.25 | -11.7 | -11.53 | -9.95 | -8.72 | -12.51 | -5.23 | -9.05 | -11.66 | -11.91 | -8.78 | -5.57 |
| EPS Diluted
| -9.34 | -56.79 | -4.89 | -4.93 | -4.84 | -6.79 | -9.26 | -7.75 | -7.72 | -2.6 | -6.94 | -8.73 | -7.24 | -10.11 | -14.15 | -16.28 | -16.4 | -13.72 | -14.79 | -15.54 | -13.55 | -11.43 | -12.17 | -9.77 | -12 | -11.75 | -11.68 | -10.25 | -11.7 | -11.53 | -9.95 | -8.72 | -12.51 | -5.23 | -9.05 | -11.66 | -11.91 | -8.78 | -5.57 |
| EBITDA
| -18.337 | 160.476 | -18.806 | -18.777 | -18.354 | -22.045 | -24.038 | -20.031 | -19.881 | -6.307 | -17.854 | -22.407 | -17.872 | -21.338 | -18.868 | -21.909 | -22.041 | -18.515 | -17.557 | -15.233 | -12.167 | -9.595 | -8.175 | -6.56 | -7.929 | -6.658 | -6.279 | -5.507 | -6.267 | -5.462 | -4.567 | -3.968 | -3.392 | -1.414 | -2.452 | -3.169 | -3.024 | -1.055 | -0.193 |
| EBITDA Ratio
| 0 | 233.25 | -94.98 | -111.768 | -105.483 | -35.272 | -17.649 | -5.497 | -14.211 | -0.46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.035 | -5.414 | -4.426 | -6.288 | -4.502 | -6.394 | -4.416 | -5.454 | -3.978 | -5.317 | -2.503 | -3.161 | -0.413 | 0 | 0 | 0 | 0 | 0 |